Retrospective Study
Copyright ©The Author(s) 2020.
World J Hepatol. Sep 27, 2020; 12(9): 641-660
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.641
Table 4 Metastases, recurrences and outcome
CaseMetastasis and/or recurrence (Yes or No)The target sites of metastases/recurrences1Postoperative liver metastases (Right and/or left side)Disease-free survival (yr)Overallsurvival(yr)Follow-up term (yr)Prognosis (Dead or alive)
1No--2.42.42.4Alive
2No--2.35.05.0Alive
3No--3.63.63.6Alive
4No--3.63.63.6Alive
5YesLiverRight side0.40.80.8Alive
6No--8.08.08.0Alive
7YesPeritoneal cavity-2.02.82.8Dead
8YesLiverRight side1.42.02.0Dead
9YesPeritoneal cavity-0.10.20.2Dead
10YesLocal site, hepatic hilum-1.22.62.6Dead
11YesPerineal cavity-0.81.01.0Dead
12YesLocal site, liverLeft side0.10.20.2Dead
13YesPeritoneal cavity, paraaortic LN-0.41.71.7Dead
14YesLocal site-0.93.43.4Dead
15YesParaaortic LN-4.05.45.4Alive
16YesBone, paraaortic LN-2.07.57.5Alive
17YesLiver remnantLeft side0.60.70.7Dead
18YesLiverRight and left sides0.20.30.3Dead
19YesLiver, local site, paraaortic LNLeft side0.61.01.0Dead